Nicardipine and verapamil attenuate the pressor response to laryngoscopy and intubation
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patients. Les patients du groupe I refoivent du solutd physiologique alors que les groupes Het Ili refoivent soit de 17~y-drochlorure de nicardipine 0,03 mg' kg -t ou de l~ydrochlorure de vdrapamil 0,1 mg" kg -1 trois minutes avant la laryngoscopie et l~ntubation. Les patients du groupe I manifestent l'augmentation la plus importante de PAS it 25,4 + 2,2 mmHg et de Fc 35,7 + 3,8 b" rain -tune minute apr~s l'intubation (P < 0,001) et ces changements persistent pendant la p~riode d~tude mais en diminuant. Aprks l'administration de la drogue, les patients du groupe H et III manifestent des augmentations de la Fc de 26 q-2,4 et de 2,2 b" min -t et des baisses de PAS de 24,8 • 2,0 et de 18,8 + 2,4 mmHg respectivement (P < 0,001). En conclusion, la nicardipine et le v~rapamil attdnuent la r~ponse vaso-pressive de la laryngoscopie et de l~ntubation mais ne contrtlent pas la tachycardie qui en rdsulte.
Laryngoscopy and tracheal intubation are known to resuit in transient hypertension, tachycardia and arrhythmias which can be deleterious in patients with systemic hypertension, coronary artery disease, aortic aneurysms, intracranial aneurysms and cerebrovascular disease.l-5 Various pharmacological attempts have been made to attenuate these responses. These include opioids, 6 deep anaesthesia,7 local anaesthetics, s vasodilators, 9 alpha and beta sympathetic blocking agents l0 and calcium channel blocking drugs, t t
The calcium channel blocking drugs used for attenuation of these cardiovascular responses include intravenous verapamil, n,12 intravenous diltiazem ~3 and intravenous nicardipine hydrochloride. ~4,J5 In the present study we compared the efticaey of two calcium channel blocking agents, nicardipine hydrochloride, a dihydropyridine derivative and verapamil hydrochloride, a papaverine derivative, for attenuation of the pressor responses to laryngoscopy and intubation.
Methods
Forty-five adult patients of ASA grades I-II, undergoing elective surgery, were selected for the present study. Eth-CAN J ANAESTH 1994/ 41:12 / pp 1185-8 ical clearance was obtained from the institute ethics committee and informed consent was obtained from the patients. Those with major systemic illness, pregnant women and lactating mothers, and patients in whom intubation took more than 30 see were excluded from the study. Premeditation wfis with diazepam 0.15 mg. kg-l po the night before surgery and repeated 90 min before surgery. In addition, morphine sulphate 0.15 mg. kg -t, promethazine hydrochloride 0.5 nag. kg -I were administered im 45 min before surgery.
In the operating theatre each patient was connected to a multichannel monitor Horizon I000 for continuous ECG display and non-invasive blood pressure and heart rate measurements. Base line recordings of systolic, diastolic and mean blood pressure and heart rate were made. Blood gas analysis was also done at this time. A separate ECG recorder was connected to patients for recording of any relevant ECG changes.
Patients were randomized to receive either normal saline (Group I), 0.03 mg. kg-I nicardipine hydrochloride (Group II), or 0.1 mg. kg -I verapamil hydrochloride (Group III), three minutes before tracheal intubation. Each injection was made up to a volume of 5 ml and its nature was unknown to the observer. The drug/saline injection was followed two minutes later by thiopentone 5 rag. kg-I, /v over 30 see, followed by succinylcholine, 1.5 mg. kg -I. Artificial ventilation was commenced via a face mask using a Magill circuit. Thirty seconds later, i.e., three minutes after the drug/saline injection, laryngoscopy was performed and the trachea was intubated. Anaesthesia was maintained with 67% nitrous oxide in 02 and pancuronium was used for muscle relaxation. No other inhalational agent was used.
A second ABG analysis was done after intubation and analysed to ensure normocarbia. Readings of systolic, diastolic and mean blood pressures and heart rate were taken after the injection of the drug/saline at the following times: The data collected were analysed using paired Student's t test for comparison within the group, repeated measures ANOVA for differences among the three groups and Student's unpaired t test for differences between individual groups. Post Hoe test (Newman Keul's) was also applied for pair wise comparison. 
Results
There were no differences between the three groups with respect to mean age and weight (32. 
Changes in systolic blood pressure (SBP)
In Group I, a marked increase in SBP occurred during laryngoscopy (L), which reached its peak, 25.4 + 2.2 mmHg (P < 0.001) above basal value, at I l and the peak was sustained until 12. The SBP remained above basal level until 130 (P < 0.001) (Figure 1 ). In Groups II and III the mean maximum decrease in SBP was seen at D150, measuring 24.8 4-2.08 mmHg (P < 0.001) and 18.8 -t-2.4 mmHg (P < 0.001) respectively. In Group II, following laryngoscopy and intubation, SBP always remained below the basal value, until the end of the study period (P < 0.05, Figure 1) . In Group III, SBP was comparable to the basal value at It, after which it decreased and remained so throughout the study ( Figure  1 ).
Changes in diastolic blood pressure (DBP)
Apart from changes in magnitude and duration, the changes of DBP were similar to those of SBP. The maximum change seen in DBP was +23 + 3.0 mmHg (P < 0.001) at I~ in Group I, -14.5 4-1.4 mmHg (P < 0.001) at DI50 in Group II and -12.73 4-1.1 mmHg (P < 0.001) at DI50 in Group III. In Groups II and III, DBP was same at all times except for a greater decrease in Group II at D120 (Figure 2 ).
Changes in mean blood pressure (MBP)
The pattern of changes in MBP was similar to SBP and DBP (Figure 3) . 
Changes in heart rate (HR)
Group I had the greatest increase in heart rate (HR) after tracheal intubation, compared with Groups II and III (Figure 4) . In Group I, HR increased with laryngoscopy and intubation (35.7 -t-3.8 beats min -I, P < 0.001) and remained above the basal levels throughout the study. In Groups II and III, HR increased after drug administration, but the peak increase in HR was seen at It measuring 26 + 2.5 beats, rain -! in Group II and 15.1 + 2.17 beats, min -t in Group III (Figure 4) . The HR remained higher in Group II than in Group III (P < 0.05) except at It (Figure 1 ).
Discussion
Calcium channel blocking agents are widely used for their cardiovascular and cerebrovascular actions. 16 Verapamil is the treatment of choice in supraventricular tachycardias and a useful antihypertensive and antianginal agent. It has also been used for successful attenuation of the cardiovascular responses to laryngoscopy and intubation. H,I 2 However, it cannot be administered safely with volatile anaesthetic agents, t7 or beta adrenergic blocking agents, ~s.~9 in patients who have poor left ventricular function. It can also potentiate neuromuscular blockade. 20 In this respect, nicardipine has been combined with digoxin 21 and beta blocking agents 22,23 and has no neuromuscular blocking effect. However, when used with inhalational agents it may cause excessive hypotension. 24 Puri et al. (1986) , using higher doses of morphine (0.2 mg-kg -t) and thiopentone (5.5 rag-kg-t), achieved better control of heart rate responses using verapamil 0.1 mg" kg -~/v one rain before induction, t t Nishikawa and Namiki (1989) , on the other hand, using the same dose of verapamil after succinylcholine could not control hypertension and tachycardia, t2 This could' have been due FIGURE 3 Changes in mean blood pressure. FIGURE 4 Changes in heart rate.
to two factors. First, the time allowed for verapamil to act (one min) was not sufficient for its peak action. Secondly, precurarisation may result in tachycardia and hypertension. 25 In our study, we achieved control of hypertension with verapamil but the tachycardia could not be controlled.
Our patients showed a greater decrease in systemic blood pressure with nicardipine than described by Mikawa et al. (1990) 14 and Omote et al. (1992) , Is perhaps because, in these two studies, opioid premedication was not used.
Our study shows that nicardipine and verapamil are effective in attenuating the hypertensive response to laryngoscopy and tracheal intubation, but neither controlled the resulting tachycardia.
In summary, calcium channel blockers provide sarisfactory control of hypertension but some other agents, e.g., opioids, may be needed to attenuate the tachycardia resulting from laryngoscopy and intubation.
